{"disease":{"id":"complicated-skin-or-skin-structure-infection","name":"complicated skin or skin structure infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01175707","title":"Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":80,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}